Bit Capital Gmb H Day One Biopharmaceuticals, Inc. Transaction History
Bit Capital Gmb H
- $1.17 Trillion
- Q1 2025
A detailed history of Bit Capital Gmb H transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Bit Capital Gmb H holds 116,565 shares of DAWN stock, worth $736,690. This represents 0.08% of its overall portfolio holdings.
Number of Shares
116,565
Previous 171,714
32.12%
Holding current value
$736,690
Previous $2.18 Billion
57.51%
% of portfolio
0.08%
Previous 0.17%
Shares
5 transactions
Others Institutions Holding DAWN
# of Institutions
196Shares Held
76.7MCall Options Held
138KPut Options Held
208K-
Atlas Venture Life Science Advisors, LLC6.43MShares$40.6 Million14.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.94MShares$37.6 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$36.4 Million0.95% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$28.7 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL4.06MShares$25.7 Million0.14% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $464M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...